Conversation Continues: Addressing the Persistent Gap in Female Sexual Health for Cancer Survivors.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41512225.
- Also identified by DOI 10.1200/OP-25-00863.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sexual dysfunction is a common yet under-recognized and distressing side effect of cancer treatment among female survivors. Despite its significant impact on quality of life, sexual health is often poorly integrated into survivorship care due to barriers at the provider, patient, and system levels. These barriers include limited provider training, time constraints, discomfort, and a lack of clear clinical guidelines. Marginalized populations such as LGBTQ2SIA+ individuals, older women, and racial and ethnic minorities face additional disparities in care. Patients may avoid raising concerns due to stigma, misinformation, or cultural taboos. At the system level, fragmented care models, lack of interdisciplinary collaboration, and insufficient resources further limit effective support. Although evidence-based interventions and updated guidelines are available, they remain underused. Addressing sexual health in oncology requires a comprehensive equity-driven approach that includes provider education, standardized screening, interdisciplinary referrals, and inclusive communication. Integrating sexual health into survivorship care is essential for improving patient outcomes and delivering holistic cancer care.